Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny ...
A new UCLA study has found that artificial intelligence could help doctors identify prostate cancer patients most ...
A UCLA-developed nanoparticle is aiming to reprogram the liver in humans to attack pancreatic cancer with an mRNA vaccine (curved, hatched red lines) and an immune-activating fragment of genetic ...
This year, the Outpatient Theranostics Center at UCLA Health celebrates its first anniversary of many. UCLA Health is celebrating one year of treating patients with advanced prostate, thyroid and ...
UCLA co-led study is first trial analyzing a targeted therapy drug specifically made for brain tumors. In an international study co-led by UCLA Health Jonsson Comprehensive Cancer Center ...
A new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit from targeted treatment that removes cancer while sparing healthy tissue, ...